Biomedical Engineering Reference
In-Depth Information
107. Gilbert D. Treatment of actinic keratoses with sequential combination of
5-fl uorouracil and photodynamic therapy. J Drugs Dermatol 2005; 4:
161-3.
108. Martin G. Prospective, case-based assessment of sequential therapy with
topical fl uorouracil cream 0.5% and ALA-PDT for the treatment of
actinic keratosis. J Drugs Dermatol 2011; 10: 372-8.
109. Shaffelburg M. Treatment of actinic keratoses with sequential use of
photodynamic therapy and imiquimod 5% cream. J Drugs Dermatol
2009; 8: 35-9.
110. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol
2002; 146: 1-6.
111. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review
of clinical trials in the treatment of actinic keratoses and nonmelanoma
skin cancer. Br J Dermatol 2007; 156: 793-801.
112. Albert MR, Weinstock MA. Keratinocyte carcinoma. CA Cancer J Clin
2003; 53: 292-302.
113. Krosl G, Korbelik M, Dougherty GJ. Induction of immune cell infi ltra-
tion into murine SCCVII tumor by photofrin-based photodynamic
therapy. Br J Cancer 1995; 71: 549-55.
114. Szeimies RM, Morton CA, Sidoroff A, Braathen LR. Photodynamic ther-
apy for nonmelanoma skin cancer. Acta Derm Venereol (Stockh) 2005;
85: 483-90.
115. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photody-
namic therapy: report of a workshop of the British Photodermatology
Group. Br J Dermatol 2002; 146: 552-67.
116. Morton CA, Whitehurst C, Moseley H, et al. Comparison of photody-
namic therapy with cryotherapy in the treatment of Bowen's disease. Br J
Dermatol 1996; 135: 766-71.
117. Salim A, Leman JA, McColl JH, et al. Randomized comparison of
photodynamic therapy with topical 5-fl uorouracil in Bowen's disease.
Br J Dermatol 2003; 148: 539-43.
118. Morton CA, Whitehurst C, Moore JV, MacKie RM. Comparison of red
and green light in the treatment of Bowen's disease by photodynamic
therapy. Br J Dermatol 2000; 143: 767-72.
119. Morton C, Horn M, Leman J, et al. Comparison of topical methyl
aminolevulinate photodynamic therapy with cryotherapy or fl uoracil
for treatment of squamous cell carcinoma in situ. Arch Dermatol 2006;
142: 729-35.
120. Morton CA, Horn M, Leman J, et al. A randomised, placebo-
controlled, European study comparing MAL-PDT with cryotherapy and
5-fl uorouracil in subjects with Bowen's disease: results from a 24 months
follow-up. Poster presented at the 10th World Congress on Cancers of
the Skin, Vienna, 2005. P129.
121. Thestrup-Pedersen K, Ravnborg L, Reymann F. Morbus Bowen.
A description of the disease in 617 patients. Acta Derm Venereol 1988;
68: 236-9.
122. Leman JA, Mackie RM, Morton CA. Recurrence rates following amino-
laevulinic acid photodynamic therapy for intraepidermal squamous cell
carcinoma compare favourably with outcome following conventional
modalities. Br J Dermatol 2002; 147: 35.
123. Morton CA, Whitehurst C, McColl JH, et al. Photodynamic therapy for
large or multiple patches of Bowen's disease and basal cell carcinoma.
Arch Dermatol 2001; 137: 319-24.
124. Brookes PT, Jhawar S, Hinton CP, et al. Bowen's disease of the nipple - a
new method of treatment. Breast 2005; 14: 65-7.
125. Tan B, Sinclair R, Foley P. Photodynamic therapy for subungual Bowen's
disease. Australas J Dermatol 2004; 45: 172-4.
126. Usmani N, Stables GI, Telfer NR, Stringer MR. Subungual Bowen's dis-
ease treated by topical aminolevulinic acid-photodynamic therapy. J Am
Acad Dermatol 2005; 53: S273-6.
127. Souza CS, Felicio LB, Bentley MV, et al. Topical photodynamic therapy
for Bowen's disease of the digit in epidermolysis bullosa. Br J Dermatol
2005; 153: 672-4.
128. Guillen C, Sanmartin O, Escudero A, et al. Photodynamic therapy for
in situ squamous cell carcinoma on chronic radiation dermatitis after
photosensitization with 5-aminolaevulinic acid. J Eur Acad Dermatol
Venereol 2000; 14: 298-300.
129. Morton CA, Horn M, Leman J, et al. A randomized, placebo-controlled,
European study comparing MAL-PDT with cryotherapy and 5-fl uoracil
in subjects with Bowen's disease. J Eur Acad Dermatol Venereol 2004;
18: 415.
130. Morton CA. Methyl aminolevulinate: actinic keratosis and Bowen's
disease. Dermatol Clin 2007; 25: 81-7.
131. Fink-Puches R, Soyer HP, Hofer A, et al. Long-term follow-up and histo-
logical changes of superfi cial nonmelanoma skin cancers treated with
topical delta-aminolevulinic acid photodynamic therapy. Arch Derma-
tol 1998; 134: 821-6.
132. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical
delta-aminolaevulinic acid as an appropriate approach to the routine
treatment of superfi cial non-melanoma skin tumours. J Photochem
Photobiol B 1995; 29: 53-7.
133. Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology.
Arch Dermatol 1998; 134: 207-14.
134. Calzavara-Pinton PG, Venturini M, Sala R, et al. Methylaminolaevlinate-
based photodynamic therapy of Bowen's disease and squamous cell car-
cinoma. Br J Dermatol 2008; 159: 137-44.
135. Morton CA, McKenna KE, Rhodes LE; British Association of Derma-
tologists Therapy Guidelines and Audit Subcommittee and the British
Photodermatology Group. Guidelines for topical photodynamic ther-
apy: update. Br J Dermatol 2008; 159: 1245-66.
136. Braathen LR, Szeimies RM, Basset-Seguin N, et al. International Society
for Photodynamic Therapy in Dermatology. Guidelines on the use of
photodynamic therapy for nonmelanoma skin cancer: an international
consensus. International Society for Photodynamic Therapy in Derma-
tology, 2005. J Am Acad Dermatol 2007; 56: 125-43.
137. McCormack CJ, Kelly JW, Dorevitch AP. Differences in age and body site
distribution of the histological subtypes of basal cell carcinoma. A pos-
sible indicator of differing causes. Arch Dermatol 1997; 133: 593-6.
138. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endog-
enous protoporphyrin IX: basic principles and present clinical experi-
ence. J Photochem Photobiol B 1990; 6: 143-8.
139. Morton CA, Whitehurst C, McColl JH, et al. Photodynamic therapy for
large or multiple patches of Bowen disease and basal cell carcinoma.
Arch Dermatol 2001; 137: 319-24.
140. Clark C, Bryden A, Dawe R, et al. Topical 5-aminolaevulinic acid
photodynamic therapy for cutaneous lesions: outcome and comparison
of light sources. Photodermatol Photoimmunol Photomed 2003; 19:
134-41.
141. Wang I, Bendsoe N, Klinteberg CA, et al. Photodynamic therapy vs.
cryosurgery of basal cell carcinomas: results of a phase III clinical trial.
Br J Dermatol 2001; 144: 832-40.
142. Blume JE, Oseroff AR. Aminolevulinic acid photodynamic therapy for
skin cancers. Dermatol Clin 2007; 25: 5-14.
143. Horn M, Wolf P, Wulf HC, et al. Topical methyl aminolevulinate
photodynamic therapy in patients with basal cell carcinoma prone to
complications and poor cosmetic outcome with conventional therapy.
Br J Dermatol 2003; 149: 1242-9.
144. Vinciullo C, Elliott T, Gebauer K, Spelman L, Ngyen R. MAL-PDT in
patients with basal cell carcinoma: results of an Australian multicenter
study. Poster presented to the International Skin Cancer Conference
2004, Zurich, Switzerland, July 22-24, 2004.
145. Thissen MR, Neumann MH, Schouten LJ. A systematic review of treat-
ment modalities for primary basal cell carcinomas. Arch Dermatol 1999;
135: 1177-83.
146. Rowe DE, Carroll RJ, Day CI Jr. Long term recurrence rates in previ-
ously untreated (primary basal cell carcinoma): implications for subject
follow-up. J Dermatol Surg Oncol 1989; 15: 315-28.
147. Basset-Seguin N, Ibbotson SH, Emtestam L, et al. Topical methyl amino-
laevulinate photodynamic therapy versus cryotherapy for superfi cial
basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 2008; 18:
547-53.
148. Szeimies RM, Ibbotson S, Murrell DF, Rubel D, Frambach Y. A clinical
study comparing methyl aminolevulinate photodynamic therapy and
surgery in small superfi cial basal cell carcinoma (8-20 mm), with
a 12-month follow-up. J Eur Acad Dermatol Venereol 2008; 22:
1302-11.
149. Vinciullo C, Elliott T, Francis D, et al. Photodynamic therapy with topi-
cal methyl aminolaevulinate for 'diffi cult-to-treat' basal cell carcinoma.
Br J Dermatol 2005; 152: 765-72.
150. Tierney E, Barker A, Ahdout J, et al. Photodynamic therapy for the treat-
ment of cutaneous neoplasia, infl ammatory disorders and photoaging.
Dermatol Surg 2009; 35: 725-46.
